Filing Details

Accession Number:
0001104659-24-108769
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-10-15 20:12:45
Reporting Period:
2024-10-14
Accepted Time:
2024-10-15 20:12:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1819576 Liquidia Corp LQDA Pharmaceutical Preparations (2834) 851710962
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1854414 Russell Schundler 419 Davis Drive, Suite 100
Morrisville NC 27560
General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-10-14 2,576 $11.11 486,048 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 14,500 Indirect By Spouse
Footnotes
  1. Transaction effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 15, 2023.
  2. These shares of common stock were sold to cover taxes associated with the settlement of restricted stock units ("RSUs") that were initially granted to the Reporting Person on January 11, 2023.
  3. Includes (i) 58,594 unvested RSUs of the 104,167 RSUs granted to the Reporting Person on January 11, 2023, (ii) 110,135 RSUs granted to the Reporting Person on January 11, 2024, none of which have vested as of the date of this Form 4 and (iii) 9,656 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.
  4. The reporting person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.